Chryso Pierides
Impact in
- Genetics top 10%
- Myeloproliferative Neoplasms: Diagnosis and Treatment
-
- Immune cells in cancer
- Immunotherapy and Immune Responses
Papers in
-
- Chronic Myeloid Leukemia Treatments 3
- Acute Myeloid Leukemia Research 1
- Genetics 3
- Myeloproliferative Neoplasms: Diagnosis and Treatment 3
- Co-authors
- PAUL ARISTIDES Costeas (10 shared papers)Panagiotis Papageorgis (3 shared papers)Laura Koumas (4 shared papers)John Daniel Martin (2 shared papers)Chrysovalantis Voutouri (2 shared papers)Fotios Mpekris (2 shared papers)Triantafyllos Stylianopoulos (2 shared papers)Myrofora Panagi (2 shared papers)
In The Last Decade
Chryso Pierides
12 papers receiving 517 citations
Peers
Comparison fields: 5 of 53
- Genetics 89
- Immunology 137
- Oncology 155
- Biomaterials 79
- Hematology 55
Countries citing papers authored by Chryso Pierides
This map shows the geographic impact of Chryso Pierides's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chryso Pierides with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chryso Pierides more than expected).
Fields of papers citing papers by Chryso Pierides
This network shows the impact of papers produced by Chryso Pierides. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chryso Pierides. The network helps show where Chryso Pierides may publish in the future.
Co-authors
The 25 scholars most cited alongside Chryso Pierides, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 163 | |
| 2 | 2022 | 88 | |
| 3 | 2020 | 87 | |
| 4 | 2020 | 62 | |
| 5 | 2013 | 50 | |
| 6 | 2014 | 38 | |
| 7 | 2017 | 14 | |
| 8 | 2018 | 7 | |
| 9 | 2023 | 5 | |
| 10 | 2015 | 3 | |
| 11 | 2022 | 3 | |
| 12 | A sensitive detection method for MPLW515L or MPLW515K mutation inmyeloproliferative disorders | 2014 | 1 |
About Chryso Pierides
Chryso Pierides is a scholar working on Hematology, Genetics, Immunology, Oncology and Biomaterials, having authored 12 papers that have together received 521 indexed citations. Recurring topics across this work include Chronic Myeloid Leukemia Treatments (3 papers), Cancer Cells and Metastasis (3 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (3 papers), Reproductive System and Pregnancy (2 papers), Nanoparticle-Based Drug Delivery (2 papers), Immune cells in cancer (2 papers), Acute Myeloid Leukemia Research (1 paper) and Nanoplatforms for cancer theranostics (1 paper). The work is most often cited by research in Genetics (89 citations), Immunology (137 citations), Oncology (155 citations), Biomaterials (79 citations) and Hematology (55 citations). Chryso Pierides has collaborated with scholars based in Cyprus, Japan and Greece. Frequent co-authors include PAUL ARISTIDES Costeas, Panagiotis Papageorgis, Laura Koumas, John Daniel Martin, Chrysovalantis Voutouri, Fotios Mpekris, Triantafyllos Stylianopoulos, Myrofora Panagi, Kazunori Kataoka and Horacio Cabral. Their work appears in journals such as Frontiers in Immunology, Theranostics, Cytotherapy, Advanced Science and International Journal of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.